First Trust Advisors
XERS icon

First Trust Advisors’s Xeris Biopharma Holdings XERS Stock Holding History

First Trust Advisors’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.84M Buy
+484,978
New +$3.1M ﹤0.01% 1716

Other funds holding XERS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Swiss National Bank
Swiss National Bank Zurich, Switzerland $191B AUM 45.21% 1-Year Est. Return

First Trust Advisors's XERS Position: Q2 2026 in Review

First Trust Advisors opened a new position in Xeris Biopharma Holdings (XERS) in Q2 2026: 484,978 shares worth $3.84M. The stake represents ﹤0.01% of the portfolio and ranks #1716 among its holdings.

95 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

  • First Trust Advisors held 484,978 shares of Xeris Biopharma Holdings worth $3.84M as of Q2 2026.
  • Xeris Biopharma Holdings was a new First Trust Advisors position in Q2 2026.
  • Xeris Biopharma Holdings made up ﹤0.01% of First Trust Advisors's portfolio in Q2 2026, its #1716 holding.
  • 95 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on First Trust Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.